Logo image
Back
Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing
Journal article   Peer reviewed

Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing

Jingjing Zheng, Tong Li, Huijing Ye, Zehang Jiang, Wenbing Jiang, Huasheng Yang, Zhikun Wu and Zhi Xie
Cancer letters, Vol.598, p.217121
08/28/2024
DOI: 10.1016/j.canlet.2024.217121
PMID: 39009069

View Online

Abstract

Retinoblastoma (RB) is the most common intraocular malignancy in childhood. The causal variants in RB are mostly characterized by previously used short-read sequencing (SRS) analysis, which has technical limitations in identifying structural variants (SVs) and phasing information. Long-read sequencing (LRS) technology has advantages over SRS in detecting SVs, phased genetic variants, and methylation. In this study, we comprehensively characterized the genetic landscape of RB using combinatorial LRS and SRS of 16 RB tumors and 16 matched blood samples. We detected a total of 232 somatic SVs, with an average of 14.5 SVs per sample across the whole genome in our cohort. We identified 20 distinct pathogenic variants disrupting RB1 gene, including three novel small variants and five somatic SVs. We found more somatic SVs were detected from LRS than SRS (140 vs. 122) in RB samples with WGS data, particularly the insertions (18 vs. 1). Furthermore, our analysis shows that, with the exception of one sample who lacked the methylation data, all samples presented biallelic inactivation of RB1 in various forms, including two cases with the biallelic hypermethylated promoter and four cases with compound heterozygous mutations which were missing in SRS analysis. By inferring relative timing of somatic events, we reveal the genetic progression that RB1 disruption early and followed by copy number changes, including amplifications of Chr2p and deletions of Chr16q, during RB tumorigenesis. Altogether, we characterize the comprehensive genetic landscape of RB, providing novel insights into the genetic alterations and mechanisms contributing to RB initiation and development. Our work also establishes a framework to analyze genomic landscape of cancers based on LRS data.
 Life Sciences & Biomedicine Oncology Science & Technology

Details

Metrics

1 Record Views
6 Times Cited - Web of Science
Logo image